SCFAs, especially butyrate, strengthen the integrity of the gut barrier, reducing intestinal permeability and systemic inflammation
doi:10.1001/jama.2024.9217
Kyowa Hakko Bio Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., and Lesaffre are at the forefront, collectively holding a significant share, leveraging expertise in high-purity production, nutraceutical formulations, and large-scale supply chain operations
Second, the EEG endpoint that defined the compounds activity is a population-level pattern in the recipient cortex, not a molecular readout meaning the discovery established a phenomenology, not a pathway
In the present study, the rat serum was treated with the helium APP device